H. Barth

2.3k total citations
72 papers, 1.6k citations indexed

About

H. Barth is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, H. Barth has authored 72 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Epidemiology. Recurrent topics in H. Barth's work include Polyamine Metabolism and Applications (21 papers), Enzyme function and inhibition (13 papers) and Amino Acid Enzymes and Metabolism (9 papers). H. Barth is often cited by papers focused on Polyamine Metabolism and Applications (21 papers), Enzyme function and inhibition (13 papers) and Amino Acid Enzymes and Metabolism (9 papers). H. Barth collaborates with scholars based in Germany, Netherlands and Austria. H. Barth's co-authors include W. Lorenz, M. Hutzel, Jürgen Kusche, Α. Doenicke, W Lintz, A. Schmal, H. Giertz, H. J. Reimann, E. Werle and M. Meyer‐Wittkopf and has published in prestigious journals such as Journal of the American College of Cardiology, JNCI Journal of the National Cancer Institute and Pain.

In The Last Decade

H. Barth

71 papers receiving 1.5k citations

Peers

Countries citing papers authored by H. Barth

Since Specialization

Citations

This map shows the geographic impact of H. Barth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Barth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Barth more than expected).

Fields of papers citing papers by H. Barth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Barth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Barth. The network helps show where H. Barth may publish in the future.

Co-authorship network of co-authors of H. Barth

This figure shows the co-authorship network connecting the top 25 collaborators of H. Barth. A scholar is included among the top collaborators of H. Barth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Barth. H. Barth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A short history of Theoretical Surgery 2004 ·Inflammation Research ·Michael Koller, H. Barth, İ. Çeli̇k, Μ. Rothmund	1
2	Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature 2001 ·Ultrasound in Obstetrics and Gynecology ·M. Meyer‐Wittkopf, H. Barth, Günter Emons, Stephan Schmidt	52
3	Three‐dimensional (3‐D) ultrasonography for obtaining the four and five‐chamber view: comparison with cross‐sectional (2‐D) fetal sonographic screening 2000 ·Ultrasound in Obstetrics and Gynecology ·M. Meyer‐Wittkopf, (unknown), (unknown), H. Barth, Stephan Schmidt	42
4	Mycotic Pseudoaneurysm of the Aorta in Children 2000 ·Pediatric Cardiology ·H. Barth, Rainer Moosdorf, Jürgen Bauer, Dietmar Schranz, Hakan Akintürk	32
5	Saruplase Is a Safe and Effective Thrombolytic Agent; Observations in 1698 Patients: Results of the PASS Study 1999 ·Journal of Thrombosis and Thrombolysis ·Frank Vermeer, (unknown), J. Meyer, Frits W. Bär, B Charbonnier, Jürgen Windeler, H. Barth	10
6	Thrombolysis with saruplase versus streptokinase in acute myocardial infarction: Five-year results of the PRIMI Trial 1999 ·American Heart Journal ·Martin Spiecker, Jürgen Windeler, Frank Vermeer, Rolf Michels, Ricardo Seabra‐Gomes, Jürgen vom Dahl, Sebastian Kerber, Freek W.A. Verheugt, P. W. Westerhof, Frits W. Bär, Uwe Nixdorff, H. Barth, (unknown), (unknown), Jürgen Meyer	10
7	Randomized, Double-Blind Study Comparing Saruplase With Streptokinase Therapy in Acute Myocardial Infarction: The COMPASS Equivalence Trial fn1fn1This study was supported by Grünenthal GmbH, the manufacturer of saruplase. 1998 ·Journal of the American College of Cardiology ·Ulrich Tebbe, Rolf Michels, Jennifer Adgey, (unknown), Avi Caspi, B Charbonnier, Jürgen Windeler, H. Barth, Robert M. Groves, (unknown), William H. Fennell, Amadeo Betriu, Mikhail Ruda, J Mlczoch	68
8	Microdeletion 22q11 in complex cardiovascular malformations 1997 ·Human Genetics ·Yasmin Mehraein, C.-F. Wippermann, Ina Michel‐Behnke, (unknown), (unknown), (unknown), (unknown), H. Barth, (unknown), Helga Rehder	51
9	Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study) 1995 ·Journal of the American College of Cardiology ·Ulrich Tebbe, Jürgen Windeler, (unknown), Hans Hoffmann, Jarosław Wójcik, (unknown), (unknown), (unknown), (unknown), (unknown), H. Barth	28
10	[Abnormal origin of the right coronary artery from the pulmonary artery. A case report]. 1995 ·PubMed ·H. Barth, J. Apitz	2
11	The effect of taprostene in patients with acute myocardial infarction treated with thrombolytic therapy: results of the STARTstudy 1993 ·European Heart Journal ·Frits W. Bär, J. Meyer, Rolf Michels, R. Uebis, Stefan Lange, H. Barth, Robert M. Groves, Frank Vermeer	6
12	Saruplase, a new fibrin specific thrombolytic agent; efficacy and safety in the first 1000 patients 1991 ·Journal of the American College of Cardiology ·Frank Vermeer, (unknown), Jörg Meyer, (unknown), Rolf Michels, (unknown), (unknown), H. Barth, Leopold Flohé	4
13	Dose‐related healing of duodenal ulcer with the proton pump inhibitor lansoprazole 1991 ·Alimentary Pharmacology & Therapeutics ·W Londong, H. Barth, H. G. Dammann, K. J. Hengels, (unknown), Peter Müller, Holger Rohde, Bernd Simon	47
14	Effects of taprostene, a stable prostacyclin analogue, on haemodynamics, platelet function and arachidonate metabolism in healthy volunteers 1990 ·European Journal of Clinical Pharmacology ·Irene Virgolini, P Fitscha, H. Sinzinger, H. Barth	8
15	Effects of taprostene, a chemically stable prostacyclin analogue, in patients with ischaemic peripheral vascular disease: A placebo controlled double-blind trial 1989 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Irene Virgolini, P Fitscha, John O’Grady, H. Barth, H. Sinzinger	5
16	Histamine content, diamine oxidase activity and histamine methyltransferase activity in human tissues: Fact or fictions? 1984 ·Inflammation Research ·R. Hesterberg, J. Sattler, W. Lorenz, C. -D. Stahlknecht, H. Barth, M. Crombach, D. Weber	53
17	[Combination of ventricular septal defect with unilateral pulmonary artery stenoses and contralateral pulmonary hypertension]. 1984 ·PubMed ·H. Barth, A. A. Schmaltz, (unknown), J. Apitz	1
18	[Histamine and its role in peptic gastric diseases: the discovery of histamine-H2-receptor antagonists]. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·H. Barth, W Lorenz	0
19	Isolation and characterization of lipoprotein-x from the pig 1977 ·Clinica Chimica Acta ·Pierre Müller, Giovannella Baggio, H. Barth, H. Wieland, M. Reza Anari, D. Seidel	1
20	Proceedings: Effects of (+)-catechin on several enzymes of histamine metabolism and on stress ulcer formation in the female rat. 1975 ·University of Regensburg Publication Server (University of Regensburg) ·W. Lorenz, H. J. Reimann, Jürgen Kusche, H. Barth, A. Schmal, (unknown), (unknown), (unknown), Jurema Schmidt, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact